Skip to content
Home/ Targeting the DNA Damage Response for Cancer Therapy (2023)
Targeting the DNA Damage Response for Cancer Therapy (2023)

Targeting the DNA Damage Response for Cancer Therapy (2023)

No customer reviews yet ISBN 9783031300646

This book discusses the latest developments in Poly (ADP-ribose) polymerase (PARP) inhibitor drug development. It focuses on the translational and clinical development of the latest drugs, as well as the evidence for regulatory approval of PARP inhibitors in multiple different molecular subtypes and tumor indications. The most-up-to-date information on basic scientific research on DNA repair pathways and the DNA Damage Response (DDR) is also covered. Every chapter contains insight into the preclinical, translational along with clinical aspects of a specific DDR inhibitor with key and expert opinion points reinforcing the most important concepts detailed to enable the reader to develop a deep understanding of the topic.

Targeting the DNA Damage Response for Cancer Therapy comprehensively reviews the application of PARP and other DDR inhibitors across oncology disciplines. Therefore, it is a valuable resource for all medical professionals and researchers who use or who are researching the use of these inhibitors on a day-to-day basis.

About the author

Product details

Pub dateNov 18, 2023
ISBN-103031300645
ISBN-139783031300646
LanguageEnglish
Last updated 2026-09-19 15:41
$145.82
Only 2 left in stock — order soon
Delivery by Monday, October 19, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Oncology - General
See all
Facing Cancer: A Complete Guide for People with Cancer, Their Families, and Caregivers
Stern, Theodore
$20.36
Cancer Pain Management
Fisch, Michael
$251.58
MD Anderson Manual of Psychosocial Oncology
Duffy, James D
$101.14
Gynecologic Oncology: Clinical Practice and Surgical Atlas
Karlan, Beth Y
$320.70
Harrison's Manual of Oncology
Chabner, Bruce a
$95.77
Advances in Cancer Research
Volume 68 of <b>Advances in Cancer Research</b> continues the tradition of publishing up-to-date reviews and "hot" topics in cancer research. This volume begins with a "Foundations in Cancer Research" article by Harald zur Hausen that reviews his years of research on the idea that cancer can be triggered by infection. The structure and function of the cytokine receptor superfamily and its association with leukemias are discussed in depth by James Ihle. Marcia Hall and Gordon Peters review the evidence indicating that genetic abnormalities hinder the function of certain cyclins and their inhibitors. The most widely studied protooncogene, c-<i>myc</i>, is reviewed by Marie Henriksson and Bernhard Lüscher&#x3b; the chapter focuses on the function of c-<i>myc</i> as a transcription factor rather than on the effects of gene translocation and activation on malignancies. Ham Werner and Derek LeRoith present data on the role that insulin-like growth factors play on cell growth and regulation. In the final chapter, Olli-P. Kallioniemi and Tapio Visakorpi investigate the field of prostate cancer and, more importantly, the biological reason and natural history behind the growth of this cancer.
$103.10